 |
|
|
 |
|
Rationale:
- Mild, uncomplicated cellulitis should be treated out of the hospital with oral antibiotics, although it may require surgical
drainage which can also be done on an outpatient basis.
- Moderate to severe cellulitis may require hospitalization for observation, surgery, control of comorbidities, and parenteral
antibiotics.
- Parenteral antibiotics can be provided at home or in an infusion clinic if the patient is compliant to therapy and the cellulitis
is not too severe.
|
|
Evidence:
- Classification schemes for cellulitis and soft tissue infection have been reported to assist in treatment decisions (27; 48).
- According to some studies, abscesses <5 cm in diameter may be effectively treated by incision and drainage without the need
for systemic antimicrobial therapy (18; 64; 65). More recent studies show no correlation between the size of the abscesses and the relative need for concordant antibiotic
therapy (66). Non-purulent cellulitis may be treated with β-lactam antibiotics, lacking activity against MRSA (67). Purulent cellulitis may require antimicrobial agents with activity against MRSA.
|
|
Comments:
- Non-purulent cellulitis is usually caused by streptococci, and purulent cellulitis by S. aureus.
- Treatment failure may be due to resistance to the antimicrobial agent, a deeper undrained abscess, or complicating comorbidities
such as chronic venous insufficiency or arterial insufficiency.
- In some patients cutaneous inflammation worsens during the initial 24 hours after antimicrobials are begun. This is not necessarily
a sign of failure and may merely represent continued local inflammation due to the release of bacterial antigens from antimicrobial
activity (18). Anti-inflammatory agents may accelerate resolution of the clinical signs of inflammation (68; 69; 70).
|
| FAQs |
|
|
|
Dennis L. Stevens, PhD, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Lawrence J. Eron, MD, FACP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2008 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|